Kitani Tomoya 木谷友哉

… Alternative Names

KITANI Tomoya 木谷友哉

Less

Researcher Number	30842257
Other IDs	https://orcid.org/0000-0002-2696-046X
Affiliation (Current)	2024: 京都府立医科大学, 医学(系)研究科(研究院), 助教
Affiliation (based on the past Project Information) *help	2022 – 2023: 京都府立医科大学, 医学(系)研究科(研究院), 助教 2019 – 2021: 京都府立医科大学, 医学部附属病院, 専攻医
Review Section/Research Field	Principal Investigator Basic Section 53020:Cardiology-related / 0902:General internal medicine and related fields
Keywords	Principal Investigator 心筋細胞 / 心不全 / 多能性幹細胞 / 拡張不全型心不全 / 心臓線維芽細胞 / 心筋線維芽細胞 / ヒトiPS細胞 / 心筋脂肪 / ヒト多能性幹細胞由来心筋細胞 / CRISPR/Cas9 … More / 細胞死 / ヒト多能性幹細胞 / iPS細胞 / CRISPRスクリーニング / ゲノム編集 Less

Research Projects
(4 results)
Research Products
(6 results)

Targeting myocardial essential genes to develop novel therapeutic approaches against heart failurePrincipal Investigator
- Principal Investigator
  
  木谷友哉
- Project Period (FY)
  2023 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Kyoto Prefectural University of Medicine
Discovery of Therapeutic Targets for Heart Failure with Preserved Ejection Fraction using CRISPR/Cas9 Technology and Human Pluripotent Stem Cells.Principal Investigator
- Principal Investigator
  
  Kitani Tomoya
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Kyoto Prefectural University of Medicine
循環microRNAとヒト多能性幹細胞を用いた拡張型心不全の病態解明Principal Investigator
- Principal Investigator
  
  木谷友哉
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Kyoto Prefectural University of Medicine
Discovery of novel molecular mechanism to promote human cardiomyocytes survivalPrincipal Investigator
- Principal Investigator
  
  KITANI Tomoya
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Review Section
  
  0902:General internal medicine and related fields
- Research Institution
  Kyoto Prefectural University of Medicine

All 2022 2020

All Presentation

[Presentation] CRISPR-Cas9 Screen in Human Pluripotent Stem Cell-derived Cardiomyocytes Reveals Therapeutic Target for Doxorubicin-induced Cardiac Dysfunction2022
- Author(s)
  Tomoya Kitani
- Organizer
  第26回日本心不全学会総会
- Data Source
  KAKENHI-PROJECT-21K16030
[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022
- Author(s)
  木谷　友哉
- Organizer
  国際心臓研究学会日本部会総会
- Data Source
  KAKENHI-PROJECT-21K16030
[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022
- Author(s)
  Tomoya Kitani
- Organizer
  39th Annual Meeting of the ISHR-Japanese Section
- Data Source
  KAKENHI-PROJECT-21K16030
[Presentation] A CRISPR Screen in Human Pluripotent Stem Cell-Derived Cardiomyocytes Identifies a Novel Therapeutic Target for Doxorubicin-induced Cardiotoxicity2022
- Author(s)
  Tomoya Kitani
- Organizer
  66th Annual Scientific Meeting of The Korean Society of Cardiology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K16030
[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022
- Author(s)
  木谷　友哉
- Organizer
  国際心臓研究学会日本部会総会
- Data Source
  KAKENHI-PROJECT-19K23950
[Presentation] Cardiovascular Disease Modeling and Translational Research Using Human induced Pluripotent Stem Cells: Opportunity and Challenge2020
- Author(s)
  木谷　友哉
- Organizer
  2020 International Conference of Korean Society for Molecular and Cellular Biology
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K23950

Kitani Tomoya 木谷 友哉

KITANI Tomoya 木谷 友哉

Research Projects

Research Products

Targeting myocardial essential genes to develop novel therapeutic approaches against heart failurePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Discovery of Therapeutic Targets for Heart Failure with Preserved Ejection Fraction using CRISPR/Cas9 Technology and Human Pluripotent Stem Cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

循環microRNAとヒト多能性幹細胞を用いた拡張型心不全の病態解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Discovery of novel molecular mechanism to promote human cardiomyocytes survivalPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Presentation] CRISPR-Cas9 Screen in Human Pluripotent Stem Cell-derived Cardiomyocytes Reveals Therapeutic Target for Doxorubicin-induced Cardiac Dysfunction2022

Author(s)

Organizer

Data Source

[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022

Author(s)

Organizer

Data Source

[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022

Author(s)

Organizer

Data Source

[Presentation] A CRISPR Screen in Human Pluripotent Stem Cell-Derived Cardiomyocytes Identifies a Novel Therapeutic Target for Doxorubicin-induced Cardiotoxicity2022

Author(s)

Organizer

Data Source

[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022

Author(s)

Organizer

Data Source

[Presentation] Cardiovascular Disease Modeling and Translational Research Using Human induced Pluripotent Stem Cells: Opportunity and Challenge2020

Author(s)

Organizer

Data Source

Kitani Tomoya 木谷友哉

KITANI Tomoya 木谷友哉